Does a cholesterol drug help prevent heart problems in people who haven't had a heart attack or stroke?

Original Title

Rationale and Design of the Effect of EVolocumab in PatiEntS at High CArdiovascuLar RIsk WithoUt Prior Myocardial Infarction or Stroke (VESALIUS-CV) Trial.

Not medical advice. For informational purposes only. Always consult a healthcare professional. Terms

Summary

Doctors are testing a drug called evolocumab to see if it helps prevent heart attacks, strokes, and other heart problems in people at high risk but who haven't had one yet.

Proposed Mechanism

No biological mechanisms were identified in this study. This may be an epidemiological, observational, or survey-based study that reports associations rather than proposing causal biological pathways.

Quality Analysis
Methodology
55%
Moderate QualityOverall Score
Randomized Controlled TrialMedicine

Systematic Reviews & Meta-Analyses

Max 100

Randomized Controlled Trials

Max 90

Cohort Studies

Max 72

Case-Control Studies

Max 58

Cross-Sectional Studies

Max 44

Case Reports & Case Series

Max 30

Expert Opinion & Narrative Reviews

Max 5
StrongerWeaker
Randomized Controlled Trials
Level 1b
55

55 / 90

Evidence Score

Participants are randomly assigned to treatment or control groups, minimizing bias. Considered the gold standard for testing whether an intervention causes an effect.

Sign up free to unlock the full quality breakdown with evidence strength scoring, statistical analysis, and detailed methodology.